David BurrowsMedicis Pharmaceutical CorpMRXTOP PICKSep 13, 2006

Sector that has been out of favour and under owned for some time. Have had a tough 3/4 years and have been going through a restructuring. Starting to see some benefits. Kind of stock portfolio managers like to get into in a slowdown.

David Burrows

Owned

Unlock Rating

$31.29

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Uses Restolane in place of Botox. Demographically very attractive.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

David BurrowsMedicis Pharmaceutical CorpMRXTOP PICKSep 13, 2006

You might be interested:

Medicis Pharmaceutical Corp(MRX)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals